SCHEMBL13737068

SCHEMBL13737068

NOC1C(O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O

nearest known ligand 0.73

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ SLC28A1 O00337 1/20 0.73
▸ SLC28A2 O43868 1/20 0.73
▸ SLC29A1 Q99808 1/20 0.73
▸ SLC28A3 Q9HAS3 1/20 0.73
▸ P2RY2 P41231 10/20 0.52
▸ P2RY6 Q15077 7/20 0.52
▸ P2RY14 Q15391 6/20 0.52
▸ P2RY4 P51582 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL547063 1.00 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL6141707 1.00 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL7520137 0.90 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL12987975 0.89 SLC28A1 (0.70) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL12987977 0.89 SLC28A1 (0.70) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL24359130 0.88 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL19894397 0.88 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL2580965 0.88 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL14389708 0.88 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL20732056 0.88 SLC28A1 (0.73) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023175536-A1 LIPID MONOMERS FOR THERAPEUTIC DELIVERY OF RNA JANSSEN BIOTECH, INC. (US) 2023-09-21 — — WO disclosed
EP-2705159-B1 METHODS FOR SEQUENCING, AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS COMPRISING INTERNALLY LABELLED PRIMER QIAGEN GMBH (DE) 2018-03-21 — — EP disclosed
US-20140113302-A1 METHODS FOR SEQUENCING, AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS COMPRISING INTERNALLY LABELLED PRIMER QIAGEN GMBH (DE) 2014-04-24 — — US disclosed
EP-2705159-A1 METHODS FOR SEQUENCING, AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS COMPRISING INTERNALLY LABELLED PRIMER Qiagen GmbH (DE) 2014-03-12 — — EP disclosed
CN-103502475-A Methods for sequencing, amplifying and detecting nucleic acids comprising internally labeled primers QIAGEN GMBH 2014-01-08 — — CN disclosed
WO-2012152698-A1 METHODS FOR SEQUENCING, AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS COMPRISING INTERNALLY LABELLED PRIMER QIAGEN GMBH (DE) 2012-11-15 — — WO disclosed
Send feedback